103 related articles for article (PubMed ID: 5043228)
21. Effect of combined therapy with cytosine arabinoside (NSC-63878) and l,3-bis-(2-chloroethyl)-1-nitrosourea (NSC-409962) on sarcoma 180 and L1210 in vivo.
Mizuno NS; Humphrey EW
Cancer Chemother Rep; 1969 Sep; 53(4):215-21. PubMed ID: 5384462
[No Abstract] [Full Text] [Related]
22. 1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors.
Wilson CB; Boldrey EB; Enot KJ
Cancer Chemother Rep; 1970 Aug; 54(4):273-81. PubMed ID: 4334089
[No Abstract] [Full Text] [Related]
23. A phase II study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC79037) in the palliative management of advanced gastrointestinal cancer.
Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
Cancer Res; 1972 Jun; 32(6):1278-9. PubMed ID: 4113144
[No Abstract] [Full Text] [Related]
24. Enhancement of the antitumor effects of 1,3-bis(2-chloroethyl)-1-nitrosourea and cyclophosphamide by vitamin A.
Cohen MH; Carbone PP
J Natl Cancer Inst; 1972 Apr; 48(4):921-6. PubMed ID: 5023689
[No Abstract] [Full Text] [Related]
25. The response of human lymphoma cells in vitro to bleomycin and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Drewinko B; Novak JK; Barranco SC
Cancer Res; 1972 Jun; 32(6):1206-8. PubMed ID: 4113143
[No Abstract] [Full Text] [Related]
26. Alkylating agents in bronchogenic carcinoma.
Green RA; Humphrey E; Close H; Patno ME
Am J Med; 1969 Apr; 46(4):516-25. PubMed ID: 5791000
[No Abstract] [Full Text] [Related]
27. An overview of the status of the nitrosoureas in other tumors.
Carter SK
Cancer Chemother Rep 3; 1973 May; 4(3):35-46. PubMed ID: 4584034
[No Abstract] [Full Text] [Related]
28. Separate and sequential chemotherapy of mouse leukemia L1210 with 1-beta-D-arabinofuranosylcytosine hydrochloride and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Tyrer DD; Kline I; Venditti JM; Goldin A
Cancer Res; 1967 May; 27(5):873-9. PubMed ID: 6025252
[No Abstract] [Full Text] [Related]
29. Influence of tumor-host differences at a single histocompatibility locus (H-1) on the antileukemic effect of 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC 409962).
Bonmassar E; Cudkowicz G; Vadlamudi S; Goldin A
Cancer Res; 1970 Oct; 30(10):2538-42. PubMed ID: 5474176
[No Abstract] [Full Text] [Related]
30. [A strain of ascitic tumor NK-Ly, resistant to nitrosomethylurea].
Poroshenko GG; Gor'kova SN; Evseenko LS
Dokl Akad Nauk SSSR; 1968 Sep; 182(3):730-2. PubMed ID: 5737835
[No Abstract] [Full Text] [Related]
31. IN VIVO ANTIVIRAL ACTIVITY OF 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA.
SIDWELL RW; DIXON GJ; SELLERS SM; SCHABEL FM
Appl Microbiol; 1965 Jul; 13(4):579-89. PubMed ID: 14339266
[TBL] [Abstract][Full Text] [Related]
32. B.C.N.U. (1,3-bis (2-chloroethyl) -1-nitrosourea) in the treatment of advanced Hodgkin's disease.
Cipriani D; Strinchini A
Lancet; 1972 Jun; 1(7764):1345. PubMed ID: 4113442
[No Abstract] [Full Text] [Related]
33. High-dose alkylating agent therapy: a review of clinical experiences.
Cornbleet MA; Leonard RC; Smyth JF
Cancer Drug Deliv; 1984; 1(3):227-38. PubMed ID: 6399859
[No Abstract] [Full Text] [Related]
34. Effect of treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or cyclophosphamide on spleen colony-forming units and survival time of leukemic mice.
Vadlamudi S; Waravdekar VS; Choudry JN; Goldin A
Cancer Res; 1968 Jul; 28(7):1242-9. PubMed ID: 5665982
[No Abstract] [Full Text] [Related]
35. Effects of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) and its degradation products on progression of L1210 cells through the cell cycle.
Bray DA; DeVita VT; Adamson RH; Oliverio VT
Cancer Chemother Rep; 1971 Jun; 55(3):215-20. PubMed ID: 5115843
[No Abstract] [Full Text] [Related]
36. Studies on the chemotherapy of experimental brain tumors: evaluation of 1,3-bis(2-chloroethyl)-l-nitrosourea, cyclophosphamide, mithramycin, and methotrexate.
Shapiro WR; Ausman JI; Rall DP
Cancer Res; 1970 Sep; 30(9):2401-13. PubMed ID: 5475484
[No Abstract] [Full Text] [Related]
37. BCNU (NSC-409962) in the treatment of bronchogenic carcinoma.
Whittington RM; Fairly JL; Majima H; Patno ME; Prentice R
Cancer Chemother Rep; 1972 Dec; 56(6):739-43. PubMed ID: 4574055
[No Abstract] [Full Text] [Related]
38. Clinical evaluation of 1,3-bis(2-chloroethyl)-nitrosourea (BCNU; NSC-409962) with fluoxymesterone (NSC-12165) in the treatment of solid tumors.
Reyes ES; Talley RW; O'Bryan RM; Gastesi RA
Cancer Chemother Rep; 1973 Apr; 57(2):225-30. PubMed ID: 4582564
[No Abstract] [Full Text] [Related]
39. Phase II study of strepozotocin (NSC-85998) in the treatment of advanced gastrointestinal cancer.
Moertel CG; Reitemeier RJ; Schutt AJ; Hahn RG
Cancer Chemother Rep; 1971 Jun; 55(3):303-7. PubMed ID: 5115851
[No Abstract] [Full Text] [Related]
40. Studies on the chemotherapy of experimental brain tumors: evaluation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, vincristine, and 5-fluorouracil.
Shapiro WR
J Natl Cancer Inst; 1971 Feb; 46(2):359-68. PubMed ID: 4256014
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
